Search Results - E. Verner

145 | SONROTOCLAX (BGB‐11417), A NOVEL BCL2 INHIBITOR, PLUS ZANUBRUTINIB (ZANU) DEMONSTRATES DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY CLL/SLL: UPDATED PHASE 1 RESULTS Autoría: C. Y. Cheah, C. S. Tam, M. A. Anderson, A. Tedeschi, E. Verner, M. Lasica, A. Arbelaez, S. Stilgenbauer, P. Browett, S. Leitch, E. González‐Barca, M. Shadman, J. Hou, H. Eradat, D. Westerman, Y. Fang, J. Hilger, S. Patel, S. S. Opat